The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection
Open accessAbstract
The clinical course of autoimmune and infectious disease varies greatly, even between individuals with the same condition. An understanding of the molecular basis for this heterogeneity could lead to significant improvements in both monitoring and treatment. During chronic infection the process of T-cell exhaustion inhibits the immune response, facilitating viral persistence. Here we show that a transcriptional signature reflecting CD8 T-cell exhaustion is associated with poor clearance of chronic viral infection, but conversely predicts better prognosis in multiple autoimmune diseases. The development of CD8 T-cell exhaustion during chronic infection is driven both by persistence of antigen and by a lack of accessory 'help' signals. In autoimmunity, we find that where evidence of CD4 T-cell co-stimulation is pronounced, that of CD8 T-cell exhaustion is reduced. We can reproduce the exhaustion signature by modifying the balance of persistent stimulation of T-cell antigen receptors and specific CD2-induced co-stimulation provided to human CD8 T cells in vitro, suggesting that each process plays a role in dictating outcome in autoimmune disease. The 'non-exhausted' T-cell state driven by CD2-induced co-stimulation is reduced by signals through the exhaustion-associated inhibitory receptor PD-1, suggesting that induction of exhaustion may be a therapeutic strategy in autoimmune and inflammatory disease. Using expression of optimal surrogate markers of co-stimulation/exhaustion signatures in independent data sets, we confirm an association with good clinical outcome or response to therapy in infection (hepatitis C virus) and vaccination (yellow fever, malaria, influenza), but poor outcome in autoimmune and inflammatory disease (type 1 diabetes, anti-neutrophil cytoplasmic antibody-associated vasculitis, systemic lupus erythematosus, idiopathic pulmonary fibrosis and dengue haemorrhagic fever). Thus, T-cell exhaustion plays a central role in determining outcome in autoimmune disease and targeted manipulation of this process could lead to new therapeutic opportunities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Consistently, a CD8 + Tcell transcriptional profile of exhaustion correlates with beneficial outcome in AID 35,59 and response to immunotherapies. 60”
From Autoantigen-specific CD4+ T cells acquire an exhausted phenotype and persist in human antigen-specific autoimmune diseases (2024) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Emergence of Scaling in Random Networks
Barabási, A.-L., & Albert, R. (1999) · Science · doi:10.1126/science.286.5439.509 · Cited by 36,135
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,082
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Adjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 692
Personalized Treatment in Inflammatory Bowel Disease: For Another Time
Kaneider, N. C., & Kaser, A. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.09.004 · Cited by 4
Lee, J. C., Lyons, P., & McKinney, E. F. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.01.021 · Cited by 4
Self-citationFaliti, C. E., Anam, F. A., Cheedarla, N., Woodruff, M. C., Usman, S. Y., Runnstrom, M. C., Van, T. T. P., Kyu, S. Y., Ahmed, H., Morrison-Porter, A., et al. (2023) · medRxiv · doi:10.1101/2023.06.08.23291159 · Cited by 4
“8g) 58 .”
Integrating Omics into Functional Biomarkers of Type 1 DiabetesPreprint
Long, S. A., & Linsley, P. S. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041602 · Cited by 7
UFL1 promotes survival and function of virtual memory CD8 T cells
Bhatt, B., Kumar, K., Shi, H., Ganesan, D., Anazodo, F. I., Rathakrishnan, A., Zhu, H., Wanna, A., Jiang, C., Jayavelu, T., et al. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkae042 · Cited by 3
Interferon-γ release assay as an emergent powerful biomarker in systemic lupus erythematosus
Renaudineau, Y., Treiner, E., Hérin, F., Faguer, S., Pugnet, G., & Sailler, L. (2025) · Rheumatology · doi:10.1093/rheumatology/keaf186 · Cited by 3
Cimé‐Aké, E., Lima, G., Godínez-Lazarini, E., Juárez, S., Marín-López, H., Flores-Hernández, D., Flores-Hernández, I., Gómez-Rodríguez, A., Hernández‐Ramírez, D. F., Llorente, L., et al. (2025) · Clinical Immunology · doi:10.1016/j.clim.2025.110635 · Cited by 3
Wang, Y., Wu, Y., Shen, Y., Chen, Y., Zhao, Y., Zeng, X., & He, K. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101965 · Cited by 3
“13 Additionally, exhausted T cells undergo physiological changes in both epigenetics and metabolic patterns (Fig.”
Antonelou, M., Anwari, K. J., & Salama, A. D. (2026) · Nature Reviews Nephrology · doi:10.1038/s41581-026-01081-1 · Cited by 3
“By contrast, PD1 and cytotoxic T lymphocyte antigen 4 (CTLA4) overexpression on CD8 T cells is characteristic of T cell exhaustion and this transcriptome phenotype is associated with lower relapse rates in AAV 152,153 .”
T-cell exhaustion in tumor immunology: mechanisms, heterogeneity, and therapeutic strategies
Wang, R., & Guo, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1841281 · Cited by 5
“McKinney and colleagues reported that a transcriptional signature re fl ecting CD8 T-cell exhaustion was associated with poor clearance of chronic viral infection but, conversely, with better prognosis in multiple autoimmune diseases (95).”
InfluentialLuisetto, R., Ghirardello, A., Villano, G., Scanu, A., Gatto, M., de Oliveira, F. L., Pontisso, P., & Doria, A. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-eular.5397 · Cited by 3
T cell-Intrinsic Peripheral Tolerance: A Checkpoint Target to Treat Autoimmunity
Gholijani, N., Daryabor, G., & Kahmini, F. R. (2024) · Journal of Cellular Immunology · doi:10.33696/immunology.6.194 · Cited by 3
Zhang, S., Li, X., Chen, H., Gao, X., Cai, Z., & Zeng, H. (2024) · Pediatric Rheumatology · doi:10.1186/s12969-024-01008-9 · Cited by 3
“It may be associated with T-cell failure, a nonfunctional state in which antigen persists [28, 29].”
BackgroundCytotoxic Molecules as Potential Biomarkers for Active and Inactive Systemic Lupus Erythematosus
Santana-Sánchez, P., Ramírez-Pérez, A. A., Alberti‐Minutti, P., Gajón, J. A., Bonifaz, L. C., Sánchez-Escobar, N., Legorreta-Haquet, M. V., Chávez-Sanchéz, L., & Chávez-Rueda, A. K. (2025) · Biomedicines · doi:10.3390/biomedicines13071559 · Cited by 3
Expression profiling pre‐diabetic mice to uncover drugs with clinical application to type 1 diabetes
Pang, D., Irvine, K. M., Mehdi, A. M., Thomas, H. E., Harris, M. A., Hamilton‐Williams, E. E., & Thomas, R. (2015) · Clinical & Translational Immunology · doi:10.1038/cti.2015.17 · Cited by 3
Edwards, S. J., Barton, S., Bacelar, M., Karner, C., Cain, P., Wakefield, V., & Marceniuk, G. (2021) · Health Technology Assessment · doi:10.3310/hta25230 · Cited by 3
Keller, E. J., Dvorina, N., & Jørgensen, T. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020874 · Cited by 3
“Finally, it has been reported that the presence of exhausted CD8+ T cells associate with better clinical outcomes in SLE patients [38].”
BackgroundEpstein-Barr Virus et lupus systémique : quels liens ?
Enfrein, A., & Hamidou, M. A. (2022) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2022.03.341 · Cited by 3
Transcriptional reprogramming via signaling domains of CD2, CD28, and 4-1BB
Linhares, A. D. S., Sharma, S., Steinberger, P., & Leitner, J. M. (2024) · iScience · doi:10.1016/j.isci.2024.109267 · Cited by 4
T-cell exhaustion-related genes in Graves’ disease: a comprehensive genome mapping analysis
Jiang, Z., Cai, H., Lin, Y., Lin, R., Chen, L., & Huang, H. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1364782 · Cited by 3
Role of effector T cells in multiple sclerosis
Chihara, N. (2020) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12594 · Cited by 3
“All rights reserved chronic inflammation in immune-mediated diseases can vary from the initial factors involved in disrupting self-tolerance (1).”
BackgroundKruize, Z., Maurer, I., van Dort, K. A., van den Elshout, M. A. M., Hoornenborg, E., Booiman, T., Prins, M., & Kootstra, N. A. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa284 · Cited by 3
“2 • ofid • Kruize et al displayed an altered expression of genes involved in the bioenergy metabolism, implicating that metabolic changes may play an important role in T-cell exhaustion and dysfunction observed during chronic viral infection [9, 10].”
BackgroundResultLeavy, O. (2015) · Nature reviews. Immunology · doi:10.1038/nri3890 · Cited by 3
A human mutation in STAT3 promotes type 1 diabetes through a defect in CD8+ T cell tolerancePreprint
Anderson, M. S., Warshauer, J. T., Belk, J. A., Chan, A. Y. K., Wang, J., Gupta, A. R., Acenas, D. D., II, Shi, Q., Peng, Y., Phipps, J. D., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-257641/v1 · Cited by 3
Haham, N., Zveik, O., Rechtman, A., Brill, L., & Vaknin‐Dembinsky, A. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578289 · Cited by 2
DNA methylation predicts infection risk in kidney transplant recipients
Hsu, F., Pickering, H. C., Rubbi, L., Thompson, M. J., Reed, E. F., Pellegrini, M. A., & Schaenman, J. M. D. (2025) · Life Science Alliance · doi:10.26508/lsa.202403124 · Cited by 2
“…are self-reactive and differentiate into Tregs that help suppress other immune cells from attacking the body ’ s own tissues (Marrack & Kappler, 2004; McKinney et al, 2015; Saggau et al, 2024), and evidence has been proposed linking DNA methylation and autoimmune diseases (Ballestar et al, 2020).”
Altered CD27-related T cell subsets reflect immune imbalance in systemic lupus erythematosus
Chen, X., Shen, B. Q., Lin, W. V., Xiong, Z., Yang, B., Luo, H., Zong, Z., Chen, J., Bahabayi, A., & Liu, C. (2025) · Immunologic Research · doi:10.1007/s12026-025-09637-2 · Cited by 2
“There are few reports concerning the role of exhausted T cells in autoimmunity, but they have linked their presence with an improved prognosis in several autoimmune diseases [46].”
T lymphocytes linking autoimmunity and cardiovascular disease in aging
Ortega‐Sollero, E., Ruiz‐Fernández, I., & Martı́n, P. (2025) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2024.40 · Cited by 2
Recent developments in biomarker guided therapy for Crohn’s disease
Bargas, A., Torres, J., & Verstockt, B. (2025) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2025.2590179 · Cited by 2
“A CD8 T-cell gene expression signature, reflecting differences in T-cell exhaustion, has demonstrated potential to predict disease progression in both CD and UC [30,31].”
Wang, H., Zhou, Y., Tu, Y., You, J., Gao, B., Yuan, K., Zhong, S., Huang, C., Han, Q., Dai, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65615-0 · Cited by 3
Fisher, M. S., Philippova, J., Васильевич, К. В., & Sennikov, S. V. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311563 · Cited by 4
“A study by McKinney et al. outlines a strategy for inducing CD8 + T cell exhaustion in the context of infectious and autoimmune diseases [45].”
Jevtić, B., Lazarević, M. N., Miljković, Đ., & Nikolich, J. Ž. (2026) · European Journal of Immunology · doi:10.1002/eji.70163 · Cited by 3
Liu, Y., & Li, Y. (2026) · Medicine · doi:10.1097/md.0000000000047718 · Cited by 2
“[28,29] Collectively, these biomarkers integrate multi-dimensional systemic stressors implicated in the initiation and progression of CKM syndrome, thus providing a more holistic reflection of pathophysiological burden than any individual marker alone.”
Intermittent administration of tacrolimus enhances anti-tumor immunity in melanoma-bearing mice
Chen, T., Zhang, Q., Zhang, N., Liu, B., Chen, J., Huang, F., Lin, J., Lan, R., Xie, X., & Wang, Z. (2022) · Carcinogenesis · doi:10.1093/carcin/bgac017 · Cited by 2
(2021) · Frontiers research topics · doi:10.3389/978-2-88966-718-5 · Cited by 3
Is Epstein Barr virus latency protective against type 1 diabetes?
Żołędziewska, M. (2024) · Medical Hypotheses · doi:10.1016/j.mehy.2024.111314 · Cited by 2
Multiomics in autoimmune diseases
Zahoor, M., Hussain, M. S., Manzoor, Z., Ashraf, S., Ali, A., Alsaffar, R. M., & Ahmad, S. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23971-7.00008-0 · Cited by 2
Rejler, M., Füchtbauer, J. D., Davíðsdóttir, L. G., Fejrskov, A., Söderholm, J. D., Christensen, R., Andersen, V. C., Repsilber, D., Kjeldsen, J., Høivik, M. L., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-083163 · Cited by 2
Microbial mimics supersize the pathogenic self-response
Capera, J., & Dustin, M. L. (2024) · Journal of Clinical Investigation · doi:10.1172/jci184046 · Cited by 2
“It has been noted that individuals with more resilient T cell response profiles are better able to resist viral pathogens, but display greater severity of autoimmunity (11).”
BackgroundHow do autoimmune CD4+ T cells handle exhaustion?
Fabri, A., & Walker, L. S. K. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.11.004 · Cited by 2
Wang, Y., Zhou, Y., Huang, C., Wang, Y., Lou, L., Zhao, L., Xu, S., Zheng, M., & Li, S. (2025) · BMC Nephrology · doi:10.1186/s12882-025-04002-9 · Cited by 2
“…disease induced PL: For instance, Patients with SLE often exhibit T cell dysfunction, particularly an increased proportion of exhausted T cells [20], decreased IL-2 secretion [21], and a breakdown of B cell tolerance mechanisms leading to polyclonal activation and production of numerous…”
Wedel, J., Kochupurakkal, N. M., Kong, S. W., Bose, S., Lee, J.-W., Maslyar, M., Alsairafi, B., MacLeod, K., Liu, K., Zhang, H., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci172218 · Cited by 2
“In contrast, blockade of individual coinhibitory receptors may reverse Texh, for example, to enhance tumor immune responses (6–12).”
Self-citationStromal-derived factor-1: The glycoprotein fueling autoimmune storms via CXCR4 and CXCR7
Abbasifard, M., Mohammadi-Shahrokhi, V., & Khorramdelazad, H. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.146374 · Cited by 2
The SAgA of Antigen-Specific Immunotherapy for Type 1 Diabetes
Mallone, R., & You, S. (2021) · Diabetes · doi:10.2337/dbi21-0011 · Cited by 1
“Thus, states of T-cell unresponsiveness may be a common feature of tolerance restoration and, possibly, of different degrees of “benign,” quiescent autoimmunity in healthy individuals (21) and in patients with different rates of disease progression (22,23).”
BackgroundPhysiology and Pathology of Immune Dysregulation: Regulatory T Cells and Anergy
Tores, M. I., López‐Casado, M. Á., de León, C. P., Lorite, P., & Palomeque, T. (2017) · InTech eBooks · doi:10.5772/intechopen.71770 · Cited by 3
“Blockage of IL-10 restores T cell function and improves viral control during chronic viral infections, demonstrating that IL-10 promotes T cell exhaustion [128, 129].”
BackgroundOrganization of Immunological Synapses and Kinapses
Fritzsche, M., & Dustin, M. L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-803369-2.00001-2 · Cited by 2
Xue, K., Zheng, Y., Yu, R., Shen, X., & Cui, Y. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000164 · Cited by 2
“Systemic lupus erythematosus (SLE) is an autoimmune leukocyte responses.([5]) In this study, we explored the disease characterized by a broad spectrum of clinical transcriptional signature of PBMCs from clinically and manifestations.”
BackgroundMoustaka, K., Katsiougiannis, S., Τέντα, Ρ., Havaki, S., Koutsoudaki, P., Moutsopoulos, H. Μ., & Skopouli, F. N. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-eular.1438 · Cited by 2
Genetic Variant CFH rs6677604 Might Play a Protective Role in lupus Nephritis
Tao, J., Tan, M., Li, L., Chu, H. A., Song, D., Tan, Y., Wang, S., Qu, Z., & Yu, F. (2020) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2020.10.008 · Cited by 2
Li, J., Sun, X., Shen, Y., Yang, Q., & Dai, S.-Y. (2020) · Gynecologic and Obstetric Investigation · doi:10.1159/000511440 · Cited by 2
Data harnessing to nurture the human mind for a tailored approach to the child
Misra, S. C., & Mukhopadhyay, K. (2022) · Pediatric Research · doi:10.1038/s41390-022-02320-4 · Cited by 2
“This will enable prognostication of clinical course and identify potential therapeutic targets to reduce relapse in autoimmune diseases.(71) S.”
BackgroundThe Role of Exhaustion in Tumor-Induced T Cell Dysfunction in Cancer
Prado-Garcı́a, H., Romero‐Garcia, S., & López-González, J. S. (2014) · Springer eBooks · doi:10.1007/978-3-662-44006-3_5 · Cited by 2
Perspectives on the Role of T Cell Negative Immune Checkpoint Receptors in Health and Disease
Fujita, T., Clements, D. M., Premeaux, T. A., & Ndhlovu, L. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-33946-3_6 · Cited by 2
Meng, G., & Mei, H. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/240002 · Cited by 2
Single-Cell Modeling of CD8 + T Cell Exhaustion Predicts Response to Cancer ImmunotherapyPreprint
Jin, G., Xue, G., Wang, R., Wu, L., Miller, L. D., Lu, Y., & Zhang, W. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/459867 · Cited by 2
Zhang, S., Li, X., Tian, Y., Chen, H., Liang, D., Chen, K., Cai, Z., & Zeng, H. (2022) · Research Square · doi:10.21203/rs.3.rs-2272370/v1 · Cited by 2
Personalised medicine for Crohn’s disease is a cost-effective strategyPreprint
Buchanan, V., Griffin, S. C., Tahir, W., Hills, K., Parkes, M., Smith, K. G. C., Lyons, P., Lee, J. C., & McKinney, E. F. (2022) · medRxiv · doi:10.1101/2022.12.01.22281309 · Cited by 2
Self-citationBanos, A., Thomas, Κ., Garantziotis, P., Malissovas, N., Filia, A., Pieta, A., Nikolopoulos, D., Moustafa, S., Panagiotopoulos, A. G., Boumpas, D. T., et al. (2020) · Mediterranean Journal of Rheumatology · doi:10.31138/mjr.31.3.366 · Cited by 1
Tian, J., Liu, X., Liang, H., Shen, Y., Xiang, X., Zhu, F., Wang, X., Liu, C., Xu, X., Zhang, X., et al. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578308 · Cited by 1
“In autoimmune diseases, the expression of immune checkpoint molecules by immune cells can limit T cell overactivation, and protect tissues from immune-mediated inflammation and injury (McKinney et al., 2015;McComb et al., 2019; Zhang and Zheng, 2020).”
BackgroundLiu, Z., Zhao, Z., Xie, H., Lu, N., Liu, J., & Jiao, Q. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1295309 · Cited by 1
Polyarticular juvenile idiopathic arthritis has a distinct co-inhibitor receptor profile
Sağ, E., Balık, Z., Demir, S., Akça, Ü. K., Şener, S., Cüceoğlu, M. K., Atalay, E., Bocutcu, S., Vural, T., Tasdemir, N. K., et al. (2024) · Lara D. Veeken · doi:10.1093/rheumatology/keae306 · Cited by 1
Martín-Martín, C., del Riego, E. S., Vidal-Castiñeira, J. R., Zapico-González, M. S., Rodríguez-Pérez, M., Corte-Iglesias, V., Sáiz, M. L., Díaz-Bulnes, P., Escudero, D., Suárez-Álvarez, B., et al. (2024) · Vaccines · doi:10.3390/vaccines12060679 · Cited by 1
Neutralizing the IL-7Rα limits injury in experimental ANCA-associated glomerulonephritis
Alikhan, M. A., Kishimoto, K., Wong, L., Prakongtham, P., Auden, A., O’Sullivan, K. M., Jaw, J., & Kitching, A. R. (2024) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfae276 · Cited by 1
Osuch, S., Kazek, M., Emmel, P., Berak, H., Radkowski, M., & Cortés, K. C. (2025) · Scientific Reports · doi:10.1038/s41598-025-05084-z · Cited by 1
Lymphopenia drives T cell exhaustion in immunodeficient STING gain-of-function mice
Freytag, D., Giorgiutti, S., Hopsomer, G., Wadier, N., Depauw, S., Mertz, P., Augé, F., Carapito, R., Couillin, I., Korganow, A., et al. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00292-6 · Cited by 1
“Therefore, T cell exhaustion could be bene fi cial in STING GOF mice by limiting tissue immunopathology, similar to its effect in other autoin fl ammatory and autoimmune diseases (McKinney et al, 2015).”
Exhaustion‐Resistant CD8 + T Cells in Ankylosing Spondylitis: A Proposed Three‐Axis Model
Zhang, X., Lu, J., Lin, X., & Zhou, L. (2025) · Immunology · doi:10.1111/imm.70044 · Cited by 2
“Recent studies further reveal that the exhausted T cell pool is heterogeneous, comprising subsets at different differentiation stages [33, 34].”
Wang, Y., Mei, X., Zhong, J., Wang, J., Cao, J., Zheng, S., Qi, D., & Wang, Z. (2026) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-025-04297-5 · Cited by 1
Lv, X., Wang, S., Tang, J., Guo, N., Yuan, X., & Sun, Y. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-026-01926-3 · Cited by 1
“OR, odds ratio; CI, confidence interval T1DM could potentially lead to advancements in preventive and therapeutic approaches [25].”
Beyond tumor biology: nursing interventions for psychological and immune health in cancer patients
Gou, Y. R., Gu, H., & Wang, L. (2026) · Supportive Care in Cancer · doi:10.1007/s00520-026-10574-5 · Cited by 1
“T-Cell exhaustion marked by reduced proliferation and cytokine output is linked to poor survival in cancer and infections, while showing protective effects in transplant and autoimmune contexts [59–62].”
Arsenio, J., Kahia, N., Robertson, S., Rodriguez, M., Layug, P. J., Vats, H., Kannan, K., Spicer, V., Ozturk-Aptekmann, A., & Wilkins, O. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1783098 · Cited by 2
“As such, greater T cell exhaustion is associated with a better prognosis of autoimmune diseases (88 – 90) and the establishment of effector memory CD8 + T cells with hallmarks of exhaustion are critical for a successful pregnancy (91, 92).”
Xiang, M., Liu, S., Xiao, D., & Tao, Y. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02810-5 · Cited by 1
“346 Accumulating evidence indicates that LAG-3 de fi ciency is involved in accelerating the progression of T1DM in NOD mice.”
ISN Nexus 2016 Symposia: Translational Immunology in Kidney Disease—The Berlin Roadmap
Anders, H., Rovin, B. H., Jayne, D. R. W., Brunetta, P. G., Coppo, R., Davidson, A., Devarapu, S. K., de Zeeuw, D., Duffield, J. S., Eulberg, D., et al. (2016) · Kidney International Reports · doi:10.1016/j.ekir.2016.06.009 · Cited by 1
“29 Once identi fi ed this may serve as an early predictor of fl ares or as a therapeutic target to sustain T-cell exhaustion for the maintenance of remission.”
BackgroundSelf-citationImmunopathology of the Endocrine System
Rosol, T. J., & Walling, B. E. (2017) · Molecular and integrative toxicology · doi:10.1007/978-3-319-47385-7_13 · Cited by 1
Prognosis and Outcomes of ANCA-Associated Vasculitis
Jayne, D. R. W. (2019) · Rare diseases of the immune system · doi:10.1007/978-3-030-02239-6_16 · Cited by 1
Self-citationImmunotherapy for Autoimmune Diseases
Mali, A. V., Sawant, A., Mahadik, A., & Nair, S. (2020) · Springer eBooks · doi:10.1007/978-981-15-9038-2_4 · Cited by 1
Suárez‐Fueyo, A., Crispín, J. C., & Tsokos, G. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47927-1.00010-4 · Cited by 1
Medicina de precisión en la enfermedad inflamatoria intestinal
Mínguez, A., & Nos, P. (2022) · Acta gastroenteorológica latinoamericana/Acta gastroenterológica latinoamericana · doi:10.52787/agl.v52i3.245 · Cited by 1
KAT2B expression on CD4+T lymphocytes in pediatric systemic lupus erythematosus
Hossny, E. M., El-Ghoneimy, D. H., Hamza, M., Radwan, N. M., & abdelnaby, M. (2022) · The Egyptian Journal of Pediatric Allergy and Immunology · doi:10.21608/ejpa.2022.264505 · Cited by 1
“SLEDAI was interpreted as follow: no activity equals 0, mild activity (1-5), moderate activity (6-10), severe activity (11-19) and very high severe activity ≥ 20.”
BackgroundDual immune checkpoints inhibition: Cancer treatment and immunological modes of action
Ramteke, A. S. (2023) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v13i6.5880 · Cited by 1
PRANDOTA, J. (2023) · Journal of Clinical Medicine Current Research · doi:10.53043/2832-7551.jcmcr.3.007 · Cited by 2
Stefanski, A., Dorner, T. E., & Kneitz, C. (2023) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-023-01408-4 · Cited by 1
Transferrin Disassociates TCR from CD3 Signaling Apparatus to Promote Metastasis
Cheng, R., Tang, X., Zhao, Q., Wang, Y., Chen, W., Wang, G., Wang, C., Mwangi, J., Lu, Q., Tadese, D. A., et al. (2024) · Research · doi:10.34133/research.0578 · Cited by 2
Saleki, K., & Rezaei, N. (2024) · Integrated science · doi:10.1007/978-3-031-73061-0_21 · Cited by 1
Lin, W., Kartawinata, M., Jebson, B. R., Restuadi, R., Peckham, H., Radziszewska, A., Deakin, C. T., Ciurtin, C., Wedderburn, L. R., & Wallace, C. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012859 · Cited by 1
“…cell fractions from bulk expression data and infer average cell-type expression in a set of samples (e.g., cases or controls), but imputing sample-level cell-type expression is required for more detailed analyses, such as relating expression to quantitative traits, and is less commonly addressed.”
Jishu, J. A., Galic, C., Shata, A., Montclare, G., Leggett, H., Halalsheh, R., Fawzy, M. S., & Toraih, E. A. (2025) · American Journal of Rhinology and Allergy · doi:10.1177/19458924251386200 · Cited by 1
“26,27 Overall, the observed reductions of UAI, especially allergic rhinitis and chronic sinusitis, suggest immune system alterations that may confer protection against mucosal in fl ammation.”
ANCA-assoziierte Vaskulitiden – Update 2017
de Groot, K. (2017) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0043-108713 · Cited by 1
Neuropathic Pain in A Patient with Relapsing-Remitting Multiple Sclerosis – A Case Report
Kalcev, G., Barbov, I., & Zisovska, E. (2020) · Acta Scientific Medical Sciences · doi:10.31080/asms.2020.04.0584 · Cited by 1
A blood-based prognostic biomarker in inflammatory bowel diseasePreprint
Lee, J. C., Biasci, D., Noor, N. M., Pombal, D., Hou, M., Lewis, N., Ahamd, T., Hart, A., McKinney, E. F., Lyons, P., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.17863/cam.38798 · Cited by 1
Self-citationFighting Fire with Format: Exploiting Autoantigen Delivery to Combat Autoimmunity
Griffin, J. D. (2019) · KU ScholarWorks (The University of Kansas) · Cited by 1
Oh, S., Geistlinger, L., Ramos, M., Blankenberg, D. J., van den Beek, M., Taroni, J., Carey, V. J., Greene, C. S., Waldron, L., & Davis, S. R. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.26.445900 · Cited by 1
Dustin, M. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.11005-7 · Cited by 1
Klocperk, A., Friedman, D. J., Schlaak, E. A., Unger, S., Paračková, Z., Goldacker, S., Šedivá, A., Bengsch, B., & Warnatz, K. (2022) · Research Square · doi:10.21203/rs.3.rs-1359086/v1 · Cited by 1
Peng, Z., Lin, X., Liang, X., Lin, Z., Lin, W., & Wei, S. (2022) · Research Square · doi:10.21203/rs.3.rs-1558403/v1 · Cited by 1
Extra-islet expression of islet antigen boosts T-cell exhaustion to prevent autoimmune diabetesPreprint
Selck, C., Jhala, G., George, D. J. D., Kwong, C.-T. J., Christensen, M. K., Pappas, E. G., Liu, X., Ge, T., Trivedi, P., Kallies, A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.12.528226 · Cited by 1
T Cell Differentiation in Autoimmune Type 1 DiabetesPreprint
Schietinger, A., McBain, I. T., Hawley, K. M., & Miakicheva, S. (2025) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041592 · Cited by 2
Fotoran, W. L. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2017.tde-14072017-144533
Griffin, M. D. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.11.015
New approaches to induce tolerance in autoantigen-specific memory T cells in type 1 diabetes
Selck, C. (2018) · Minerva Access (University of Melbourne)
Genetic and Genomic Markers for Prognostication
Noor, N. M., Parkes, M., & Lee, J. C. (2019) · Springer eBooks · doi:10.1007/978-3-030-11446-6_27
Self-citation
Metadata
- Authors
- McKinney, E. F., Lee, J. C., Jayne, D. R. W., Lyons, P. A., & Smith, K. G. C.
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- McKinney, Eoin F.
- Smith, Kenneth G. C.
- Venue
- Nature
- Published
- 2015-06-29
- Volume
- 523
- Issue
- 7562
- Pages
- 612-616
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4623162
- OpenAlex
- W2103056503
- Cited by
- 685
- References
- 56
- Citations by year
- 2026: 45 · 2025: 54 · 2024: 82 · 2023: 45 · 2022: 81 · 2021: 65 · 2020: 73 · 2019: 74 · 2018: 65 · 2017: 48 · 2016: 40 · 2015: 10
- FWCI
- 26.79
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- Wellcome Trust (083650/Z/07/Z, 104064, 104064/Z/14/Z, 100140, 079895/Z/06/Z, 083650, 079895, 100140/Z/12/Z, 094227, 094227/Z/10/Z, 079895/Z/06/B)
- Medical Research Council (MR/L019027/1)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- T cell exhaustion, CD8+ T cells, PD-1, chronic viral infection, autoimmune disease, inflammatory diseases, prognosis, hepatitis C virus, vaccine response, type 1 diabetes, systemic lupus erythematosus, antineutrophil cytoplasmic antibody-associated vasculitis, idiopathic pulmonary fibrosis, dengue hemorrhagic fever, gene expression signatures, autoreactivity
- MeSH terms
- Animals, Autoimmune Diseases, Humans, Infections, Inflammation, Lupus Erythematosus, Systemic, Phenotype, Receptors, Antigen, T-Cell, Inflammatory Bowel Diseases, CD4-Positive T-Lymphocytes, Autoimmunity, CD8-Positive T-Lymphocytes, CD2 Antigens, Receptors, Interleukin-7, Mice, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Transcriptome, Programmed Cell Death 1 Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review